Table 1.

Summary of metabolism-modulating drugs

Drug name	Clinical trial	Phase
Statins
Simvastatin	NCT04348695	II
	NCT05542095	I
Rosuvastatin	NCT04472611	III
	NCT04359095	III
	NCT04472611	III
	NCT05594615	I
Atorvastatin	NCT04631536	III
	NCT04486508	III
	NCT04952350	III
	NCT04380402	II
	NCT04813471	III
	NCT04904536	III
	NCT04801940	III
	NCT04380402	II
	NCT04466241	III
ASM inhibitors
Fluoxetine	NCT04377308	IV
	NCT05041907	II
	NCT05283954	III
	NCT04920838	III
	NCT04780152	III
Fluvoxamine	NCT04718480	II
	NCT04342663	II
	NCT04668950	III
	NCT04727424	III
	NCT05087381	IV
	NCT04510194	III
	NCT04711863	II
NSAIDs
Aspirin	NCT05073718	III
	NCT04368377	II
	NCT04324463	III
	NCT04365309	III
	NCT04381936	III
	NCT04808895	III
	NCT04466670	II
	NCT04937088	II
	NCT04768179	III
Paracetamol	NCT04920838	III
	NCT04673214	III
	NCT04416334	III
	NCT04536051	III
Naproxen	NCT04325633	III
Montelukast
Montelukast	NCT04718285	II
	NCT04695704	III
	NCT05094596	IV
	NCT04389411	III
Omega-3 fatty acids
Omega-3 fatty acids	NCT04836052	III
	NCT05121766	I
	NCT04647604	II
	NCT04495816	II
	NCT04553705	III
	NCT04460651	III
	NCT04335032	III
	NCT05711810	IV
2-DG
No available clinical trials
Metformin
Metformin  Metformin glycinate	NCT04510194 NCT04626089 NCT04625985	III II II